Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of X worm versus Vermox mebendazole in schoolchildren with Ascaris lumbricoides or hookworm infection in Northwest Ethiopia
PACTR202503808932606Phase 4Completed
- Sponsor
- University of Gondar
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mebendazole in ascariasis and hookworm infection (2 arms), sponsored by University of Gondar. Primary endpoint: Cure rate. Started Jan 2021; status: completed.
02
Drugs
mebendazole
03
Conditions
ascariasishookworm infection
Beyond the preview
Go deeper on PACTR202503808932606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202503808932606.